vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and TFI International Inc. (TFII). Click either name above to swap in a different company.

TFI International Inc. is the larger business by last-quarter revenue ($921.9M vs $487.7M, roughly 1.9× CLOVER HEALTH INVESTMENTS, CORP.).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

TFI International Inc. is a Canadian transport and logistics company based in Saint-Laurent, Quebec, a borough of Montreal. It operates primarily in Canada, the United States, and Mexico through 4 business segments: less than truckload (LTL), package and courier, logistics, and truckload. It has Canada's largest LTL business, largest trucking fleet, and in 2021 was ranked 6th in terms of revenue among both LTL and truckload North American carriers. Its trucking fleet consists of over 14,000 c...

CLOV vs TFII — Head-to-Head

Bigger by revenue
TFII
TFII
1.9× larger
TFII
$921.9M
$487.7M
CLOV

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CLOV
CLOV
TFII
TFII
Revenue
$487.7M
$921.9M
Net Profit
$-49.3M
Gross Margin
Operating Margin
-10.1%
8.4%
Net Margin
-10.1%
Revenue YoY
44.7%
Net Profit YoY
-123.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
TFII
TFII
Q4 25
$487.7M
Q3 25
$496.6M
$921.9M
Q2 25
$477.6M
$2.0B
Q1 25
$462.3M
$2.0B
Q4 24
$337.0M
Q3 24
$331.0M
$1.0B
Q2 24
$356.3M
$2.3B
Q1 24
$346.9M
$1.9B
Net Profit
CLOV
CLOV
TFII
TFII
Q4 25
$-49.3M
Q3 25
$-24.4M
Q2 25
$-10.6M
$98.2M
Q1 25
$-1.3M
$56.0M
Q4 24
$-22.1M
Q3 24
$-9.2M
Q2 24
$7.4M
$117.8M
Q1 24
$-19.2M
$92.8M
Gross Margin
CLOV
CLOV
TFII
TFII
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
TFII
TFII
Q4 25
-10.1%
Q3 25
-4.9%
8.4%
Q2 25
-2.2%
8.4%
Q1 25
-0.3%
5.8%
Q4 24
-6.4%
Q3 24
-2.7%
9.5%
Q2 24
2.0%
9.2%
Q1 24
-6.5%
8.1%
Net Margin
CLOV
CLOV
TFII
TFII
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
4.8%
Q1 25
-0.3%
2.9%
Q4 24
-6.6%
Q3 24
-2.8%
Q2 24
2.1%
5.2%
Q1 24
-5.5%
5.0%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
TFII
TFII
Cash + ST InvestmentsLiquidity on hand
$78.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
Total Assets
$541.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
TFII
TFII
Q4 25
$78.3M
Q3 25
Q2 25
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Q1 24
$208.3M
Stockholders' Equity
CLOV
CLOV
TFII
TFII
Q4 25
$308.7M
Q3 25
$340.9M
Q2 25
$344.2M
Q1 25
$336.1M
Q4 24
$341.1M
Q3 24
$342.2M
Q2 24
$324.9M
Q1 24
$292.5M
Total Assets
CLOV
CLOV
TFII
TFII
Q4 25
$541.0M
Q3 25
$559.7M
Q2 25
$575.0M
Q1 25
$583.7M
Q4 24
$580.7M
Q3 24
$653.0M
Q2 24
$674.2M
Q1 24
$671.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
TFII
TFII
Operating Cash FlowLast quarter
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
TFII
TFII
Q4 25
$-66.9M
Q3 25
$12.1M
Q2 25
$5.4M
Q1 25
$-16.3M
Q4 24
$34.8M
Q3 24
$50.0M
Q2 24
$44.8M
Q1 24
$25.9M
Free Cash Flow
CLOV
CLOV
TFII
TFII
Q4 25
$-69.0M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
Q1 24
$25.5M
FCF Margin
CLOV
CLOV
TFII
TFII
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Q1 24
7.3%
Capex Intensity
CLOV
CLOV
TFII
TFII
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
CLOV
CLOV
TFII
TFII
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons